PIEZO1 and neoplasm: Aberrant NFAT activation is linked to tumor progression (Hope et al., 2022; Yang et al., 2022c) and fibrosis (Cai et al., 2021; Xie et al., 2022), indicating Piezo1’s potential role in pathological gene reprogramming.